Laparoscopic Power Morcellators Market: Market Size & Forecast 2026

Laparoscopic power morcellators are electromechanical surgical instruments designed to divide large tissues into smaller fragments during minimally invasive procedures, enabling surgeons to extract specimens through small trocar ports. This approach is a cornerstone of laparoscopic surgery, which is performed through small abdominal or pelvic incisions rather than large open cuts, resulting in reduced postoperative pain, shorter recovery times, and lower infection risk compared to traditional open surgery. The market, while niche relative to the broader surgical devices industry, plays an important role within the minimally invasive surgery ecosystem, particularly in gynecology where uterine fibroid management is a primary application.

• •Power morcellators cut and fragment tissue for removal through small incisions during laparoscopic procedures
• •Primarily used in gynecological surgeries including hysterectomy and myomectomy for fibroid removal
• •Market valued at approximately $0.15 billion globally in 2025

The increasing preference for minimally invasive surgical techniques across hospitals and surgical centers is a primary driver, as these procedures offer patients shorter hospital stays and faster return to normal activities. The rising global prevalence of uterine fibroids and other benign gynecological conditions requiring surgical intervention is steadily expanding the patient population eligible for morcellator-assisted procedures. Additionally, ongoing technological improvements in morcellator design, such as enhanced containment systems and precision cutting mechanisms, are supporting renewed clinical adoption in various regions.

• •Growing adoption of minimally invasive surgery driven by patient benefits including reduced pain and quicker recovery
• •Rising global prevalence of uterine fibroids and other gynecological conditions requiring surgical treatment
• •Technological advancements in containment and precision morcellation devices supporting market expansion

The market is typically segmented by product type, including manual morcellators and powered morcellators, with powered devices accounting for the larger share due to their efficiency and surgeon preference in complex procedures. By application, gynecological surgeries dominate the market, with urological and general surgical applications representing smaller segments. Geographically, North America and Europe have historically been the largest markets, supported by advanced healthcare infrastructure and high adoption rates of minimally invasive technologies, while the Asia-Pacific region is anticipated to see accelerated growth due to improving healthcare access and increasing surgical volumes in emerging economies.

• •Powered morcellators hold the majority share over manual devices due to surgical efficiency and precision
• •Gynecological applications dominate, particularly uterine fibroid removal and hysterectomy procedures
• •North America and Europe lead the market, with Asia-Pacific showing the fastest regional growth trajectory

What are the recent trends and outlook?

The market is expected to maintain its growth trajectory through the forecast period, with the broader trend toward minimally invasive surgery continuing to drive demand across developed and emerging healthcare systems. Increased regulatory scrutiny around tissue containment and the risk of occult malignancy spread has led to the development of bag-contained morcellation systems, representing a meaningful product innovation trend. Looking ahead, convergence with robotic-assisted surgery platforms and the integration of advanced imaging guidance into laparoscopic workflows are likely to influence how morcellation devices are designed and deployed in clinical practice.

• •Contained morcellation systems are emerging as a key innovation response to safety and regulatory concerns
• •Integration with robotic-assisted and image-guided laparoscopic platforms may reshape device design
• •Market projected to sustain a 7.5% annual growth rate, reaching approximately $0.22 billion by 2030